Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Supply Of Liposomal Doxorubicin (Doe), Ceftriaxone (Doe), Meropenem (Doe), Ipraatropium Association (Doe) And Salbutamol (Doe) And Dexamethasone (Doe) (Doe) (Doe)

Name: Supply Of Liposomal Doxorubicin (Doe), Ceftriaxone (Doe), Meropenem (Doe), Ipraatropium Association (Doe) And Salbutamol (Doe) And Dexamethasone (Doe) (Doe) (Doe)
Start: 2025-07-24
End: 2025-08-25
Location: OSAKIDETZA - Servicio Vasco de Salud -Director General

OSAKIDETZA - Servicio Vasco de Salud -Director General Spain has Released a tender for Supply Of Liposomal Doxorubicin (Doe), Ceftriaxone (Doe), Meropenem (Doe), Ipraatropium Association (Doe) And Salbutamol (Doe) And Dexamethasone (Doe) (Doe) (Doe) in Pharmaceuticals. The tender was released on Jul 23, 2025.

Country - Spain

Summary - Supply Of Liposomal Doxorubicin (Doe), Ceftriaxone (Doe), Meropenem (Doe), Ipraatropium Association (Doe) And Salbutamol (Doe) And Dexamethasone (Doe) (Doe) (Doe)

Deadline - Aug 25, 2025

GT reference number - 114024150

Product classification - Pharmaceutical products

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 114024150

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply of Liposomal Doxorubicin (DOE), Ceftriaxone (DOE), Meropenem (DOE), Ipraatropium Association (DOE) and salbutamol (DOE) and dexamethasone (DOE) (DOE) (DOE)local title:: Suministro de Doxorubicina Liposomal (DOE), Ceftriaxona (DOE) , Meropenem (DOE), Asociación Ipratropio (DOE) Y Salbutamol (DOE) Y Dexametasona (DOE)Contract Type: : Supplylocal description: : Suministro de Doxorubicina Liposomal (DOE), Ceftriaxona (DOE), Meropenem (DOE), Asociación Ipratropio (DOE) Y Salbutamol (DOE) Y Dexametasona (DOE)Gross Budget Euro: : 4068592.32Net Budget Euro: : 847623.4Gross Budget LC: : 4068592.32Net Budget LC: : 847623.4Tender URL: : https://www.contratacion.euskadi.eus/ac70cPub

Gt Ref Id - 114024150

Deadline - Aug 25, 2025